Literature DB >> 1808151

Results of the phase III trials with Imagent GI as an oral magnetic resonance contrast agent.

R F Mattrey1, M A Trambert, J J Brown, J N Bruneton, S W Young, G L Schooley.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1808151     DOI： 10.1097/00004424-199111001-00021

Source DB:  PubMed          Journal:  Invest Radiol        ISSN： 0020-9996            Impact factor:   6.016


× No keyword cloud information.
  2 in total

Review 1.  Perfluorocarbon Emulsion Contrast Agents: A Mini Review.

Authors:  Ryan Holman; Orane Lorton; Pauline C Guillemin; Stéphane Desgranges; Christiane Contino-Pépin; Rares Salomir
Journal:  Front Chem       Date:  2022-01-10       Impact factor: 5.221

2.  Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.

Authors:  Anne H Schmieder; Shelton D Caruthers; Jochen Keupp; Samuel A Wickline; Gregory M Lanza
Journal:  Engineering (Beijing)       Date:  2016-03-16       Impact factor: 7.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.